MacroGenics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MacroGenics and other ETFs, options, and stocks.About MGNX
MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases.
MGNX Key Statistics
Stock Snapshot
As of today, MacroGenics(MGNX) shares are valued at $1.50. The company's market cap stands at 94.89M, with a P/E ratio of -1.24.
As of 2025-12-22, MacroGenics(MGNX) stock has fluctuated between $1.50 and $1.61. The current price stands at $1.50, placing the stock 0.0% above today's low and -6.8% off the high.
MacroGenics(MGNX) shares are trading with a volume of 3.65M, against a daily average of 2.86M.
During the past year, MacroGenics(MGNX) stock moved between $0.99 at its lowest and $3.60 at its peak.
During the past year, MacroGenics(MGNX) stock moved between $0.99 at its lowest and $3.60 at its peak.
MGNX News
As the U.S. stock market navigates a mixed landscape with rising unemployment and fluctuating indices, investors are closely watching for opportunities amid the...
From what we can see, insiders were net buyers in MacroGenics, Inc.'s ( ) during the past 12 months. That is, insiders acquired the stock in greater numbers tha...
